SCHEMBL14986936

SCHEMBL14986936

C=Nc1nnc(C)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12513622 0.74
SCHEMBL13797707 0.72
SCHEMBL15943364 0.69
SCHEMBL15782595 0.69
SCHEMBL11827601 0.66 PTGS2 (0.49)
SCHEMBL14488601 0.63
SCHEMBL2210464 0.61 GAA (0.33)
SCHEMBL298980 0.59
SCHEMBL3729631 0.58
SCHEMBL10896731 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170199188-A1 METHOD OF PERFORMING ELECTROPOLYMERIZED ELECTROCHEMICALLY ACTIVE POLY-FILMS AS CURRENT SIGNAL TO DETECT BACTEREMIA NATIONAL TSING HUA UNIVERSITY (TW) 2017-07-13 US disclosed
WO-2016164401-A1 TREATMENT OF LUNG CANCER WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2016-10-13 WO disclosed
WO-2016160980-A1 METHODS OF ADMINISTERING GLUTAMINASE INHIBITORS CALITHERA BIOSCIENCES, INC. (US) 2016-10-06 WO disclosed
WO-2016014890-A1 TREATMENT OF MULTIPLE MYELOMA WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2016-01-28 WO disclosed
WO-2015061432-A1 TREATMENT OF VIRAL INFECTIONS WITH INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2015-04-30 WO disclosed
WO-2014089048-A1 TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES, INC. (US) 2014-06-12 WO disclosed
WO-2013078123-A1 HETEROCYCLIC INHIBITORS OF GLUTAMINASE CALITHERA BIOSCIENCES INC. (US) 2013-05-30 WO disclosed